ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,359,245 | -27.7% | 719,282 | -94.9% | 0.35% | -21.4% |
| Q2 2023 | $3,262,703 | +35.9% | 14,185,664 | +109.4% | 0.44% | +36.3% |
| Q1 2023 | $2,400,369 | +3.1% | 6,773,051 | -6.6% | 0.32% | -3.3% |
| Q4 2022 | $2,327,880 | -58.8% | 7,254,222 | -6.4% | 0.34% | -60.9% |
| Q3 2022 | $5,655,000 | -18.9% | 7,746,557 | 0.0% | 0.86% | -21.7% |
| Q2 2022 | $6,970,000 | +1836.1% | 7,746,557 | +3102.8% | 1.10% | +2287.0% |
| Q1 2022 | $360,000 | -31.4% | 241,867 | 0.0% | 0.05% | -13.2% |
| Q4 2021 | $525,000 | -79.4% | 241,867 | -66.3% | 0.05% | -78.9% |
| Q3 2021 | $2,553,000 | -33.3% | 717,000 | +7.5% | 0.25% | -33.6% |
| Q2 2021 | $3,829,000 | -1.6% | 667,000 | -11.1% | 0.38% | -13.1% |
| Q1 2021 | $3,892,000 | – | 750,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |